To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

IV dexamethasone extends interscalene brachial plexus block analgesia in shoulder surgery

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
December 2015

IV dexamethasone extends interscalene brachial plexus block analgesia in shoulder surgery

Vol: 4| Issue: 12| Number:19| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

A randomised controlled trial of intravenous dexamethasone combined with interscalene brachial plexus blockade for shoulder surgery

Anaesthesia. 2015 Oct;70(10):1180-5

Contributing Authors:
M Desmet B Vanneste M Reynvoet J Van Cauwelaert L Verhelst H Pottel C Missant M Van de Velde

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

240 patients undergoing arthroscopic rotator cuff repair or subacromial decompression were included in this study for the purpose of assessing how different doses of intravenous dexamethasone affected analgesic duration of interscalene blockade. The results of the study indicated that administration of both 2.5 mg and 10 mg intravenous dexamethasone, significantly extended the median time to first...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue